Archives for May 21, 2012

← 2012

FDA should reconsider capital costs of AERs: CRN

By Stephen Daniells

The Food & Drug Administration’s (FDA) position that dietary supplement adverse event reporting incurs no  capital costs or operating and maintenance costs is wrong and should be reconsidered, says the Council for Responsible Nutrition (CRN).